Developer docs
API playgroundTry for free, no card

Search company profiles

Accendra Health

Full company profile

uuid00yoxxd

Namestring
Accendra Health
Legal namestring
Accendra Health, Inc.
Company typeenum
Public
Founded yearint
2025
Descriptiontext

Accendra Health is a publicly traded (NYSE: ACH), U.S.-focused home-based care provider headquartered in Glen Allen, Virginia. The company was formed on December 31, 2025 through the divestiture of Owens & Minor's Products & Healthcare Services segment to Platinum Equity for $375 million in cash, with the remaining public parent rebranding as Accendra Health, Inc. Accendra Health delivers durable medical equipment (DME) supplies, in-home clinical support, and patient-education services to patients with chronic, complex, and acute conditions. Operations are conducted through two wholly owned brands: Apria, which provides DME and clinical support for sleep apnea, respiratory care, and negative pressure wound therapy; and Byram Healthcare, which provides DME supplies and education for diabetes, urology, ostomy, wound care, incontinence, and breast pumps. The company serves more than 3 million patients annually through a nationwide network of 250+ service locations, with payer/insurance relationships covering approximately 85% of the insured U.S. population and overall reach to more than 90% of the U.S. patient population.

The underlying technology is a home-based care delivery platform that supports DME fulfillment, recurring supply replenishment, in-home clinical scheduling, and coordination across patients, prescribers, and insurance payers. The platform does not have a public API, developer portal, or disclosed AI/ML features; the primary technical differentiator is the logistics and clinical-support network rather than a software product. Pricing is not publicly disclosed — services are reimbursed through payer/insurance contracts under a managed-services revenue model. The go-to-market is enterprise field sales plus direct-to-patient distribution through the Apria and Byram service locations, supported by brand websites, LinkedIn/X corporate presence, and a dedicated newsroom. Revenue for full-year 2025 was approximately $2.8 billion (+3% year-over-year), Q1 2026 revenue was $628 million, and management has guided 2026 revenue to $2.55–$2.65 billion. The company employs more than 6,000 teammates and is led by President & CEO Edward Pesicka.

Short descriptiontext

Accendra Health is a U.S.-focused home-based care provider (NYSE: ACH) operating through its Apria and Byram Healthcare brands, delivering durable medical equipment, in-home clinical support, and chronic-disease supplies to more than 3 million patients annually across 250+ nationwide service locations.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersGlen Allen, United States
HQ citystring
Glen Allen
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Home healthcare services, Durable medical equipment, Respiratory care products, Diabetes management supplies, In-home clinical support
Industry5 codes
1Durable Medical Equipment (DME) & Home Health Distribution
CodeCRAOAHAFPrimaryYes
2Home Respiratory & Sleep Therapy Providers (DME-Integrated)
CodeHLAFAEAFPrimaryNo
3Durable Medical Equipment (DME) Sales & Rentals
CodeHSABAKAAPrimaryNo
4Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
CodeHSABAKAHPrimaryNo
5Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
CodeHLAKANAMPrimaryNo
NAICS code3 codes
  • Home Health Care Services621610
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
  • Home Health Equipment Rental532283
SIC code3 codes
  • Services-Home Health Care Services8082
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Home Healthcare Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Home Healthcare Products and Services
TypeManaged Services
Description

Revenue generated from providing home healthcare equipment, DME supplies, and related services through Apria (respiratory care, sleep apnea, wound therapy) and Byram Healthcare (diabetes, urology, ostomy, wound care) brands. Company serves over 3 million patients annually.

accendrahealth.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Apria
Description

Founded in 1995, Apria specializes in delivering durable medical equipment (DME) supplies and in-home clinical support for conditions such as sleep apnea, comprehensive respiratory care, and negative pressure wound therapy.

accendrahealth.com
+1 more record
Core offering1 text field

Accendra Health provides home-based healthcare products and services for chronic, complex, and acute conditions through its Apria and Byram Healthcare brands. The company distributes durable medical equipment (DME) supplies and in-home clinical support for diabetes, sleep apnea, respiratory care, wound therapy, urology, ostomy, incontinence, and breast pump needs, serving over 3 million patients annually via a nationwide network of 250+ service locations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Serves over 3 million patients annually
+2 more records
Product overview1 text field

Accendra Health is a focused home-based care company (rebranded from Owens & Minor, Inc. on December 31, 2025) operating through two primary brands — Apria and Byram Healthcare — which together form one of the broadest portfolios of home health essentials. Apria delivers durable medical equipment (DME) and in-home clinical support for sleep apnea, respiratory care, and wound therapy, while Byram Healthcare provides DME supplies and education for chronic conditions including diabetes, urology, ostomy, wound care, and incontinence. The company serves over 3 million patients annually through a nationwide network of more than 250 service locations, with DME services available to approximately 85% of all insured people in the U.S.

Product and service2 records
1Apria
CategoryHome Healthcare Services
Description

Founded in 1995, Apria specializes in delivering durable medical equipment (DME) supplies and in-home clinical support for conditions such as sleep apnea, comprehensive respiratory care, and negative pressure wound therapy. It operates as a fully integrated home healthcare brand within Accendra Health.

2Byram Healthcare
CategoryHome Healthcare Services
Description

Established in 1968, Byram Healthcare specializes in providing durable medical equipment (DME) supplies and education for chronic conditions such as diabetes, urology, ostomy, wound care, incontinence, and breast pumps. It operates as a key home healthcare brand within Accendra Health.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers9 records
TypeBroad incumbent
Description

ResMed is a global leader in sleep apnea and respiratory care equipment manufacturing (CPAP, BiPAP, masks). While primarily a manufacturer rather than a DME provider, it is a key supplier/partner to Accendra's Apria sleep therapy business and a benchmark for sleep category economics.

TypeEmerging player
Description

Encompass Health operates inpatient rehabilitation hospitals and is expanding into home health and hospice. Its home-health expansion overlaps with Accendra's patient population and care setting, particularly post-acute and chronic-condition patients.

TypeDirect peer
Description

Lincare is a leading U.S. provider of respiratory therapy services and home medical equipment, with a particular strength in oxygen therapy, sleep therapy, and nebulized medications. It directly competes with Accendra's Apria brand in respiratory and sleep DME.

TypeDirect peer
Description

AdaptHealth is one of the largest U.S. providers of home medical equipment, sleep products, and diabetes supplies, serving patients nationwide through insurance and payer contracts. It is the closest publicly traded pure-play comparable to Accendra Health in DME distribution and home-based care delivery.

TypeBroad incumbent
Description

Amedisys is one of the largest U.S. home health and hospice providers, serving patients with chronic and post-acute conditions in the home setting. While more clinically focused than Accendra, it competes for the same chronically ill, home-bound patient population.

TypeDirect peer
Description

Rotech is a national provider of home medical equipment and respiratory products, including oxygen, ventilators, sleep therapy, and nebulizers. It directly competes with Accendra's Apria brand in core respiratory DME categories.

TypeDirect peer
Description

Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S. It shares Accendra's home-based care delivery model, payer-contracted revenue model, and chronic-condition patient focus.

TypeBroad incumbent
Description

Philips' Sleep & Respiratory Care business is a major manufacturer of CPAP, BiPAP, oxygen, and ventilation equipment. It competes with ResMed as a core supplier to the DME channel that Accendra operates in.

TypeOthers
Description

Now a wholly-owned sub-brand of Accendra Health, Apria was previously an independent public DME company. It serves as a useful historical benchmark and is cited here only because the standalone entity no longer exists as a peer.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accendra Health

Home Healthcare Servicesaccendrahealth.com

Accendra Health is a U.S.-focused home-based care provider (NYSE: ACH) operating through its Apria and Byram Healthcare brands, delivering durable medical equipment, in-home clinical support, and chronic-disease supplies to more than 3 million patients annually across 250+ nationwide service locations.

What Accendra Health does

Accendra Health is a publicly traded (NYSE: ACH), U.S.-focused home-based care provider headquartered in Glen Allen, Virginia. The company was formed on December 31, 2025 through the divestiture of Owens & Minor's Products & Healthcare Services segment to Platinum Equity for $375 million in cash, with the remaining public parent rebranding as Accendra Health, Inc. Accendra Health delivers durable medical equipment (DME) supplies, in-home clinical support, and patient-education services to patients with chronic, complex, and acute conditions. Operations are conducted through two wholly owned brands: Apria, which provides DME and clinical support for sleep apnea, respiratory care, and negative pressure wound therapy; and Byram Healthcare, which provides DME supplies and education for diabetes, urology, ostomy, wound care, incontinence, and breast pumps. The company serves more than 3 million patients annually through a nationwide network of 250+ service locations, with payer/insurance relationships covering approximately 85% of the insured U.S. population and overall reach to more than 90% of the U.S. patient population.

The underlying technology is a home-based care delivery platform that supports DME fulfillment, recurring supply replenishment, in-home clinical scheduling, and coordination across patients, prescribers, and insurance payers. The platform does not have a public API, developer portal, or disclosed AI/ML features; the primary technical differentiator is the logistics and clinical-support network rather than a software product. Pricing is not publicly disclosed — services are reimbursed through payer/insurance contracts under a managed-services revenue model. The go-to-market is enterprise field sales plus direct-to-patient distribution through the Apria and Byram service locations, supported by brand websites, LinkedIn/X corporate presence, and a dedicated newsroom. Revenue for full-year 2025 was approximately $2.8 billion (+3% year-over-year), Q1 2026 revenue was $628 million, and management has guided 2026 revenue to $2.55–$2.65 billion. The company employs more than 6,000 teammates and is led by President & CEO Edward Pesicka.

Accendra Health firmographics

Firmographics
Name
Accendra Health
Legal name
Accendra Health, Inc.
Website
https://accendrahealth.com
Company type
Public
Founded year
2025
Operating status
Operating
Short description
Accendra Health is a U.S.-focused home-based care provider (NYSE: ACH) operating through its Apria and Byram Healthcare brands, delivering durable medical equipment, in-home clinical support, and chronic-disease supplies to more than 3 million patients annually across 250+ nationwide service locations.
Ownership category
akta.pro rank

Accendra Health industry classification

Industry
Product category
Home Healthcare Services
NAICS
Home Health Care Services (621610), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Home Health Equipment Rental (532283)
SIC
Services-Home Health Care Services (8082), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Durable Medical Equipment (DME) & Home Health Distribution (CRAOAHAF)
akta.pro secondary industries
Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF), Durable Medical Equipment (DME) Sales & Rentals (HSABAKAA), Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

  • Home healthcare services
  • Durable medical equipment
  • Respiratory care products
  • Diabetes management supplies
  • In-home clinical support

Where Accendra Health is headquartered

Location

Headquarters

HQ city
Glen Allen
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Accendra Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Home Healthcare Products and Services: Revenue generated from providing home healthcare equipment, DME supplies, and related services through Apria (respiratory care, sleep apnea, wound therapy) and Byram Healthcare (diabetes, urology, ostomy, wound care) brands. Company serves over 3 million patients annually.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Accendra Health product offering

Product offering

Core offering

Accendra Health provides home-based healthcare products and services for chronic, complex, and acute conditions through its Apria and Byram Healthcare brands. The company distributes durable medical equipment (DME) supplies and in-home clinical support for diabetes, sleep apnea, respiratory care, wound therapy, urology, ostomy, incontinence, and breast pump needs, serving over 3 million patients annually via a nationwide network of 250+ service locations.

Product overview

Accendra Health is a focused home-based care company (rebranded from Owens & Minor, Inc. on December 31, 2025) operating through two primary brands — Apria and Byram Healthcare — which together form one of the broadest portfolios of home health essentials. Apria delivers durable medical equipment (DME) and in-home clinical support for sleep apnea, respiratory care, and wound therapy, while Byram Healthcare provides DME supplies and education for chronic conditions including diabetes, urology, ostomy, wound care, and incontinence. The company serves over 3 million patients annually through a nationwide network of more than 250 service locations, with DME services available to approximately 85% of all insured people in the U.S.

Differentiator

Problem solved

Functional benefit

Brands

  • Apria: Founded in 1995, Apria specializes in delivering durable medical equipment (DME) supplies and in-home clinical support for conditions such as sleep apnea, comprehensive respiratory care, and negative pressure wound therapy.
  • Byram Healthcare

Products and services

  • Apria Founded in 1995, Apria specializes in delivering durable medical equipment (DME) supplies and in-home clinical support for conditions such as sleep apnea, comprehensive respiratory care, and negative pressure wound therapy. It operates as a fully integrated home healthcare brand within Accendra Health.
  • Byram Healthcare Established in 1968, Byram Healthcare specializes in providing durable medical equipment (DME) supplies and education for chronic conditions such as diabetes, urology, ostomy, wound care, incontinence, and breast pumps. It operates as a key home healthcare brand within Accendra Health.

Quantifiable outcome

  • Serves over 3 million patients annually
  • +2 more outcomes

Companies that use Accendra Health

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Accendra Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Accendra Health partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves9 records

Expansion highlights4 records

Accendra Health competitors and assessment

Company assessment

Broad incumbents

  • ResMed: ResMed is a global leader in sleep apnea and respiratory care equipment manufacturing (CPAP, BiPAP, masks). While primarily a manufacturer rather than a DME provider, it is a key supplier/partner to Accendra's Apria sleep therapy business and a benchmark for sleep category economics.
  • Amedisys: Amedisys is one of the largest U.S. home health and hospice providers, serving patients with chronic and post-acute conditions in the home setting. While more clinically focused than Accendra, it competes for the same chronically ill, home-bound patient population.
  • Philips Respironics: Philips' Sleep & Respiratory Care business is a major manufacturer of CPAP, BiPAP, oxygen, and ventilation equipment. It competes with ResMed as a core supplier to the DME channel that Accendra operates in.

Emerging players

  • Encompass Health: Encompass Health operates inpatient rehabilitation hospitals and is expanding into home health and hospice. Its home-health expansion overlaps with Accendra's patient population and care setting, particularly post-acute and chronic-condition patients.

Direct peers

  • Lincare Holdings: Lincare is a leading U.S. provider of respiratory therapy services and home medical equipment, with a particular strength in oxygen therapy, sleep therapy, and nebulized medications. It directly competes with Accendra's Apria brand in respiratory and sleep DME.
  • AdaptHealth: AdaptHealth is one of the largest U.S. providers of home medical equipment, sleep products, and diabetes supplies, serving patients nationwide through insurance and payer contracts. It is the closest publicly traded pure-play comparable to Accendra Health in DME distribution and home-based care delivery.
  • Rotech Healthcare: Rotech is a national provider of home medical equipment and respiratory products, including oxygen, ventilators, sleep therapy, and nebulizers. It directly competes with Accendra's Apria brand in core respiratory DME categories.
  • Option Care Health: Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S. It shares Accendra's home-based care delivery model, payer-contracted revenue model, and chronic-condition patient focus.

Others

  • Apria Healthcare (pre-merger standalone reference): Now a wholly-owned sub-brand of Accendra Health, Apria was previously an independent public DME company. It serves as a useful historical benchmark and is cited here only because the standalone entity no longer exists as a peer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Accendra Health social profiles

Digital presence

Accendra Health compliance and trust

Trust signal

Compliance2 records

Accendra Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accendra Health leadership team

Management profile

Number of profiles

Profiles5 records

Accendra Health subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Accendra Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accendra Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accendra Health

What does Accendra Health do?

Accendra Health provides home-based healthcare products and services for chronic, complex, and acute conditions through its Apria and Byram Healthcare brands. The company distributes durable medical equipment (DME) supplies and in-home clinical support for diabetes, sleep apnea, respiratory care, wound therapy, urology, ostomy, incontinence, and breast pump needs, serving over 3 million patients annually via a nationwide network of 250+ service locations.

Is Accendra Health a public or private company?

Accendra Health is a public company. It is classified as public and is currently operating.

When was Accendra Health founded?

Accendra Health was founded in 2025.

Where is Accendra Health based?

Accendra Health is headquartered in Glen Allen, United States, in the North America region.

How does Accendra Health make money?

One revenue line is on record: home Healthcare Products and Services.

Who are Accendra Health's main competitors?

Broad incumbents on record are ResMed, Amedisys and Philips Respironics. Encompass Health is listed as an emerging player. Direct peers are Lincare Holdings, AdaptHealth, Rotech Healthcare and Option Care Health. Apria Healthcare (pre-merger standalone reference) is listed as an others.

Does Accendra Health have an API?

No public API is recorded for Accendra Health.

What industry is Accendra Health in?

Accendra Health's product category is Home Healthcare Services. Its primary akta.pro industry code is CRAOAHAF, Durable Medical Equipment (DME) & Home Health Distribution, with a secondary code of HLAFAEAF, Home Respiratory & Sleep Therapy Providers (DME-Integrated). Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seeking AlphaAccendra Health receives NYSE notice (ACH:NYSE)Accendra Health received a NYSE notice after its average closing share price fell below $1 for 30 consecutive trading days. The company plans to notify the NYSE of its intent to cure the deficiency within 10 business days and has six months to regain compliance. It is considering a reverse stock split subject to shareholder approval at its next annual meeting, expected in May 2027.Markets DailyAccendra Health (NYSE:ACH) Cut to Strong Sell at Zacks ResearchZacks Research downgraded Accendra Health from a hold to a strong sell rating. UBS, Citigroup, and others cut price targets to $1.50, and the stock opened at $0.48. The company reported a loss of $0.19 per share, missing estimates.Quiver QuantitativeLobbying Update: $200,000 of ACCENDRA HEALTH INC. lobbying was just disclosed | ACH Stock NewsACCENDRA HEALTH INC. disclosed $200,000 in lobbying spending for Q3 2026, covering home medical equipment access and reimbursement issues. The disclosure also includes institutional hedge fund activity and analyst price targets for ACH stock.AInvestAccendra Health Slashes Guidance as Payer Audits BiteAccendra Health cut its 2026 revenue forecast to $2.45-$2.55B and EBITDA to $300-$320M, triggering a 34% premarket drop. Payer audits cut Q2 revenue and EBITDA by about $10M, and CEO Ed Pesicka plans to retire by end of 2026. The company targets $100M normalized free cash flow in 2027.AInvestAccendra Health Cuts Guidance, Triggering 34% PlungeAccendra Health cut its 2026 guidance after Q2 adjusted EBITDA missed forecasts by 257.81%, triggering a 34% premarket plunge. Revenue fell 3% to $613.2 million, and the company lowered its full-year revenue outlook to $2.45–2.55 billion. CEO Ed Pesicka plans to retire by end of 2026.AInvestAccendra Health Slashes Guidance as Payer Audits Hit Cash FlowAccendra Health cut its 2026 revenue forecast to $2.45–2.55B and EBITDA to $300–320M, triggering a 34% premarket plunge. Payer audits caused $10M Q2 revenue/EBITDA losses, while sleep and diabetes segments grew 5.5% and 4% YoY. CEO Ed Pesicka plans to retire by year-end as the company targets $100M normalized free cash flow in 2027.The Motley FoolAccendra Health (ACH) Q2 2026 Earnings Call TranscriptAccendra Health reported a second-quarter net revenue of $613.2 million, a decrease from the prior year, with adjusted EBITDA falling to $60.1 million due to slower revenue growth and collection rate headwinds. The company revised its full-year guidance downward while completing a balance sheet optimization that reduced debt by $385 million, and announced CEO Edward Pesicka's intention to retire by the end of 2026.The Motley FoolAccendra Health (ACH) Q2 2026 Earnings Call TranscriptAccendra Health reported second-quarter 2026 net revenue of $613.2 million, a decline from the prior year, driven by slower growth and collection headwinds that reduced adjusted EBITDA to $60.1 million. The company revised its full-year guidance downward due to delayed cost reduction benefits and inefficient payor audits, while simultaneously completing a balance sheet optimization that reduced debt by $385 million. CEO Edward Pesicka announced his retirement by the end of 2026 as the firm undergoes transformation into a pure-play home-based healthcare provider.HME NewsAccendra Health provides update on CEO transition, credit facilityAccendra Health announced it plans to appoint a successor to CEO Edward Pesicka by mid-September, following his retirement announcement for the end of 2026. The company also confirmed it will not utilize an at-the-market equity issuance program and expects to receive approximately $45 million from the sale of two non-core assets in the third and fourth quarters.Business Wire BlogAccendra Health Updates on Capital Allocation and CEO Succession Timing PlansAccendra Health announced it will not implement its planned at-the-market equity issuance program due to current market conditions, while confirming that the decision will not impact its operational results or guidance. The company also reported that cash collections are strengthening and outlined plans to sell two non-core assets for approximately $45 million to further reduce leverage. Additionally, Accendra Health stated that its Board expects to announce a CEO successor by mid-September 2026, ahead of the current CEO's planned retirement.